Market Research Blog

A removable partial denture (RPD) is a partial denture for those patient who wants to have replacement teeth for aesthetic or functional reasons. Removable partial denture is mostly used by those people who are not eligible for fixed partial dentures and implant supported prosthesis. Removable partial denture prosthesis can be made-up from metal alloy, acrylic resin and thermoplastic resin. When required, patients can remove and reinsert a removable partial denture without professional help.

Whereas a fixed partial denture can only be removed by a dental professional. A removable partial denture is a prosthesis that replaces few missing teeth. A removable partial denture is an absolute prosthesis which is used in dental profession since years for rehabilitation of edentulous patients. Removable partial denture consists of a metal alloy which is made up of base metal alloys (usually with cobalt-chromium alloy).Acrylic teeth is attached to the metal base of removable partial denture. Metal retentive clasp are present which holds the cast partial denture in place.

These removable partial dentures are attached with the help of metal framework to keep the teeth on place. The metallic appearance of the clasp may be preventive, used for treating those patients who are very much worried about the aesthetics. Benefits of the removable partial dentures are improved chewing and speaking, reduces sagging and premature aging of the face, decreased risk of gum diseases, prevents the remaining teeth form shifting around, lowered jaw stress and tension, etc.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5278

Removable Partial Dentures Market: Drivers and Restraints

The key factors responsible for the growth of global removable partial dentures is the growing incidence of teeth loss, rising aging population and increasing disposable income. In addition, the increasing focus on providing quality dental care and growing life expectancy of the adult population is creating the need in the removable partial dentures market and hence increasing the growth of global removable partial dentures market. However, low reimbursement, fewer experienced denture technicians and poor dental insurance coverage for dental implant is restraining the growth of global removable partial dentures market.

Removable Partial Dentures Market: Overview

A removable partial denture is used to fill the gap between the teeth. Removable partial denture is attached to the teeth with the help of metal framework to keep the teeth on place. The current scenario of the global removable partial dentures market is increasing due to the majority of the population are losing their teeth due to the gum diseases or tooth decay. Acrylic material for removable partial dentures are less expensive as compared to the other materials and this increases the adoption of acrylic material. Acrylic partials are mostly used as a temporary replacement of the missing teeth. Removable partial dentures provides an additional support for a more stable and powerful bite for easier chewing. Removable partial dentures can also enhance the natural appearance and ability to speak clearly.

Removable Partial Dentures Market: Regional Overview

Region wise, the global removable partial dentures market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East and Africa. North America is expected to lead the market due to the better economic condition, advanced healthcare facilities and better government initiatives. In addition, more business investments for research and development in North America makes the region a leading market for global removable partial dentures market. Europe market is expected to hold second largest market share followed by Latin America due to increasing awareness. Asia Pacific is expected to show the moderate growth due to the lack of awareness amongst people.

Removable Partial Dentures Market: Key Players

• VITA Zahnfabrik H.
• Rauter GmbH & Co.
• KG, Yamahachi Dental Products
• Den-Mat Holdings, Kanfit 3D Ltd.
• Renishaw plc. Beta Health Association
• Inc.,Polident, Klema.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geography, grade, form and applications.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends and Issues and Challenges
• Competition & Companies involved
• Technology
• Value Chain

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5278

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Brazil, Mexico, Rest Of Latin America)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia, Rest Of Eastern Europe)
• Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC countries, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Removable Partial Dentures Market: Segmentation

The global removable partial dentures market is classified on the basis of material type, end user, and geography.

Based on material type, the global removable partial dentures market is segmented into the following:

• Acrylic
• Flexible thermoplastics
• Replacement partials
• Combination of metal/acrylic
• Cast Metal

Based on end user, the global removable partial dentures market is segmented into the following:

• Hospitals
• Dental clinics
• Dental schools
• Laboratories

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-5278

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Production and commercialization of biopharmaceutical proteins with higher therapeutic efficacy have formed a progressive landscape that continues to push the growth of plant derived proteins market. A new Future Market Insights (FMI) report forecasts that the plant derived proteins market will experience a major upturn towards 2029, reaching a value of around US$ 185 Mn. Production of three main therapeutic protein classes, including antibodies, vaccines, and replacement proteins such as albumin, insulin, growth factors, and cytokines will remain industry’s prime focus area. Plant derived proteins are recognized as natural and environmentally-sustainable than microbial and mammalian cells. Owing to these benefits, there has been an increasing demand for such proteins from biopharmaceutical companies, as raw materials for therapeutic drug production, creating an absolute opportunity for growth of the plant derived proteins market.

[240 Pages Report] A recent market study published by Future Market Insights (FMI) on the magnetic resonance imaging (MRI) contrast agents market offers global industry analysis for 2014-2018 and opportunity assessment for 2019-2029. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the magnetic resonance imaging contrast agents market, growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may make a huge impact on the development of the magnetic resonance imaging contrast agents market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the MRI contrast agents market in the coming years. The report provides detailed information about the current and future growth prospects of the magnetic resonance imaging contrast agents market in the most comprehensive way for better understanding of readers.

Data Points	Market Insights
Market Value 2022	U.S. $ 910.9 Mn
Market Value 2029	U.S. $ 1.23 Bn
CAGR 2022-2029	4.4%
Share of top 5 countries	60.8%

Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11023

Magnetic Resonance Imaging (MRI) Contrast Agents Market : Segmentation

FMI’s study on the magnetic resonance imaging contrast agents market offers information divided into three important segments— product type, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

By Product

• Paramagnetic Contrast Agents
  • Extracellular Fluid (ECF) Agents
  • Blood Pool Contrast Agents (BPCAs)
  • Organ-specific Agents
• Superparamagnetic Contrast Agent

End User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-11023

Chapter 1 – Executive Summary

The report commences with the executive summary of the MRI contrast agents market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the magnetic resonance imaging contrast agents market, as well as the key trends impacting the market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy, definition of the magnetic resonance imaging contrast agents market, and the key inclusions and exclusions in this chapter, which help readers understand basic information about MRI contrast agents.

Chapter 3 – Key Market Trends

This section highlights the key trends impacting the magnetic resonance imaging contrast agents market, which will help readers understand the current trends and their impact on market growth.

Chapter 4 – Key Success Factors

In this chapter, the reader can get information about the parent market of MRI contrast agents market. Novel use cases, product adoption by region, product USPs, number of scans by country, and how combination imaging modalities will enhance medical imaging.

Chapter 5 – Global Magnetic Resonance Imaging Contrast Agents Market Volume (In Liters) Analysis 2014-2018 and Forecast, 2019-2029

This section explains the current and future market volume (In Liters) projections and the growth trend. Readers can also get knowledge the current installed base of MRI Units, by region/ country and historical market volume (In Liters) of global magnetic resonance imaging (MRI) contrast agents market.

Chapter 6 – Global Magnetic Resonance Imaging Contrast Agents Market – Pricing Analysis

The report covers the pricing analysis of the market on the basis of region and other attributes in this chapter. It will help the reader find comparative analysis of product pricing across different regions of the globe.

Buy Complete Report@ https://www.futuremarketinsights.com/checkout/11023

Chapter 7 – Global Magnetic Resonance Imaging Contrast Agents Market Value (US$) Analysis 2014-2018 and Forecast, 2019-2029

This section explains the global market value analysis and forecast for the MRI contrast agents market during the forecast period of 2019-2029. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[179 Pages Report] Global Clinical Trials Market spending was valued at US$ 95 billion in 2019 and is expected to grow at a CAGR of 4% through 2029.

A new study of Future Market Insights (FMI) estimates the global spending on clinical trials in 2019 at ~US$ 90 Bn, recording a ~4% Y-o-Y over 2018. The healthcare sector is closing in on a new era of clinical trials, which are more engaged with patients, streamlined and connected. With development costs reaching record highs and patents approaching cliffs, companies are strengthening their R&D efforts to keep pace with change. Medical device and pharma giants are already eyeing better approaches for clinical trials, implementing a combination of their current systems and better technologies to ebb challenges in critical areas – orphan drugs and rare diseases.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[250 Pages] In 2022, global sales of viscosupplementation equipment are expected to reach US$ 1.98 billion. According to detailed industry analysis, the global viscosupplementation market is expected to grow at a CAGR of 4.8% to reach a market valuation of US$ 2.89 Bn by 2030.

According to the study, a number of broader, and industry-specific factors will drive growth in this market, which has been relatively less impacted by the sluggishness induced by COVID-19.

Global viscosuppplementation revenues are likely to reach USD 4 billion by the end of 2030, according to a new research by ESOMAR-certified firm Future Market Insights.

According to latest research by FMI, the global disposable spinal instruments market is estimated to have accounted for US$ 43.7 Mn in terms of value in 2018. The report on the disposable spinal instruments market further projects that the disposable spinal instruments market is likely to grow at a CAGR of 8.2% during the period 2019-2029.

Healthcare-Associated Infections or Hospital-Acquired Infections (HAIs) are caused while receiving medical treatment in a hospital facility. HAIs are among the major challenges to the safety of patients, and can have severe public health implications. These infections are also capable of causing disability and sometimes death. The occurrence of HAIs is increasing at an alarming rate. According to WHO, the prevalence of these infections in developed countries varies from 3.5% to 12%. Developing countries are at a higher risk as the rate of infection is 3-20 times higher in developing countries as compared to high-income countries.

Increasing number of outpatient procedures is among the economic variables affecting the spine market. A rapid shift from inpatient to outpatient surgeries for spine-related diseases is expected to create a high growth potential for disposable spinal instruments in the near future. The number of spinal surgeries is increasing with growing awareness among surgeons about cost-effective treatments.

In the U.S., more than 15 Mn surgeries are performed annually. Between 2% and 5% of patients are estimated develop a surgical site infection, which is between 160,000 and 300,000 surgical site infections nationwide each year. Surgical site infections are among the most commonly occurring HAIs in the U.S., and are the most expensive to treat. Fortunately, the adoption of various disposable devices and kits has reduced the incidence of surgical site infections and HAIs.

Thus, the increasing preference for the usage of disposable instruments for reducing the occurrence of HAIs is driving the demand for disposable instruments, which is creating growth opportunities for the disposable spinal instruments market.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-6890

The demand for disposable instruments kits in the healthcare industry is growing at a significant rate, and the demand from unconventional end-use industries is one of the major factors fuelling the market for disposable spinal instruments. Growth in the number of end users, apart from hospitals, such as orthopaedic clinics and Ambulatory Surgical Centres (ASCs), is expected to create high demand for disposable spinal instruments. Moreover, the adoption of disposable instrument kits by various end users has reduced the risk of infections and cross-contamination, which has resulted in a reduction in the number of HAIs.

Increase in the number of use cases of disposable spinal instruments in hospitals and ASCs is expected to boost the global demand for disposable instrument kits. According to CDC, the number of Medicare-certified ASCs has increased steadily from 239 in 1983 to 5,316 in 2010.

Moreover, increasing geriatric population, which is prone to various types of spinal injuries, is estimated to boost the need for surgeries. This is expected to contribute to the demand for disposable spinal instruments. The increasing requirement of instrument kits during surgeries among the greying population, coupled with improved life expectancy, has created significant growth opportunities for the manufactures of disposable spinal instruments market. However, factors such as stringent regulations and the generation of a significant amount of waste due to the usage of disposable kits is expected to lower the growth of disposable spinal instruments in the forecast period.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-6890

The disposable spinal instruments kits segment is a leading segment in terms of revenue by product type in the disposable spinal instruments market, with a 64.5% revenue share in 2018. These kits are most widely used in cervical and lumbar surgeries such as spinal fusion and decompression surgeries. Among the procedure type segments, the spinal fusion sub-segment accounts for the largest revenue share in the disposable spinal instruments market. Among all the end users in the disposable spinal instruments market, the hospitals sub-segment is expected to be a prominent segment, followed by the orthopaedic clinics sub-segment.

The disposable spinal instruments market has been analysed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA. North America, followed by Europe, is a prominent region in the global disposable spinal instruments market. North America accounted for a revenue share of 45.8% in 2018 in disposable spinal instruments market. Europe, accounting for the second-largest revenue share, is followed by East Asia in the disposable spinal instruments market. India, China, and Brazil are emerging markets in the disposable spinal instruments market. China is one of the fastest-growing emerging markets in the global disposable spinal instruments market, and is projected to grow at a CAGR of 11.2% over the forecast period of 2019-2029.

The disposable spinal instruments market report tracks some of the key companies operating in the disposable spinal instruments market, such as

ECA Medical, Providence Medical Technology, Inc., Xenco Medical, Paradigm Spine, Intelligent Implant Systems, LLC, Safe Orthopaedics, SA , TeDan Surgical Innovations, LLC, and Joimax GmbH.

Majority of the regional players in the disposable spinal instruments market are focused on increasing their product reach and connectivity with the regional distributors of disposable spinal instruments. The manufacturers of disposable spinal instruments are focusing on collaborating with established hospitals and ASCs to sell products as some of the medical practitioners are particular about the type and brand of products used for a surgical procedure.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-6890

Key Segment

By Product Type

Instrument Kits

Cervical

Lumbar

Systems

By Procedure

Spinal Fusion

Decompression Surgeries

By End User

Hospitals

Orthopaedic Clinics

Ambulatory Surgical Centers

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

The growth of weight loss and obesity management market is attributed to the rising epidemic of obesity across the globe. According to the latest research by Future Market Insights (FMI), the global weight loss and obesity management market is anticipated to reach a valuation of over US$ 4.9 Bn, by the end of 2028. The weight loss and obesity management market is expected to expand at a steady CAGR of 5.2%, over the forecast period of 2018-2028.

Key Players:

• Novo Nordisk A/S,
• GlaxoSmithKline plc.,
• F. Hoffmann-La Roche AG,
• Allergan Plc,
• Johnson & Johnson Services, Inc,
• Medtronic plc.,
• Vivus Inc.,
• Eisai Co., Ltd.,
• ReShape Lifesciences, Inc,
• Obalon Therapeutics,
• Aspire Bariatrics,
• Allurion Technologies Inc.,
• Nalpropion Pharmaceuticals, Inc., and
• Beijing Noble Laser Technology Co., Ltd.

Key Vendors Targeting Extension of Product Portfolio

Leading companies operating in weight loss and obesity management market are majorly focusing on strengthening their product portfolio. Product line extensions help companies to launch newer products with unique features for specific indications. This results in an increased market share of companies in the highly competitive weight loss and obesity management market. In response to increasing demand from various healthcare professionals to effectively treat obesity with minimum long-term side effects, manufacturers are focusing on developing innovative and specific products.

Product innovation is expected to boost revenue and volume growth of the weight loss and obesity management market during the forecast period. For instance, an additional FDA patents approval for VIVUS, Inc.’s Qsymia, for the covering compositions of Qsymia and covering methods for effecting weight loss using Qsymia (phentermine and topiramate).

However, the high cost involved in research and development of obesity drugs is a great challenge for the growth of the weight loss and obesity management market. Additionally, long gestation time required for research and developmental activities as well as the need for a number of essential clinical trials to test drugs adds up to significant expenditure. The limitations posed by high development cost of anti-obesity drugs might hinder the growth of the global weight loss and obesity management market. Moreover, the high cost of surgical procedures, such as gastric bypass surgery, adjustable gastric banding, gastric sleeve surgery and gastric balloon treatment, may also affect the growth of the global weight loss and obesity management market adversely.

The global weight loss and obesity management market is estimated based on product type, and distribution sales. Based on product type, the weight loss and obesity management market has been segmented into drugs and devices.

Drugs product type segment is further segmented into GLP-1 receptor agonists, lipase inhibitors, serotonin receptor agonist, a combination drug, and others. Devices product type segment is further segmented into liposuction devices, bariatric stapling devices, gastric band, gastric balloon systems, gastric emptying systems, and gastric electrical stimulation systems.

Devices segment is expected to hold maximum market share in the global weight loss and obesity management market. Based on distribution sales, the weight loss and obesity management market has been segmented into institutional sales and retail sales. In terms of revenue, institutional sales dominated the global weight loss and obesity management market in 2017.

Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-411

Additional Questions Answered

Some of the additional questions addressed in this report on the weight loss and obesity management market-

• What is the revenue potential of the weight loss and obesity management market across the regions of emerging economies?
• Who are the key competitors in the weight loss and obesity management market and what are their portfolios?
• What are the major challenges influencing the growth of the weight loss and obesity management market?

Segmentation

On the basis of product type

• drugs
• devices

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-411

On the basis of distribution sales

• institutional sales
• retail sales

On the basis of geographical

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa (MEA)
• emerging countries like China, Brazil, and India.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Sales of smart pill boxes and bottles are likely to reach around 800 thousand in 2019. According to a new analytical research study by Future Market Insights (FMI), smart pill boxes and bottles market will remain a high growth-low volume landscape over the course of next few years. Over 43% of total sales will be accounted by smart pill boxes. The report envisages a higher rate of adoption for smart pill bottles.

Almost 70% of adult patients are observed to discontinue or manipulate drug therapy, resulting in non-adherence to prescribed medication. The study opines that this directly adds to the economic burden on healthcare delivery system in form of emergency cases and Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1710

Smart pill boxes and bottles are increasingly being perceived as a potential solution to such challenges posed by increased healthcare delivery costs. Significance of medication adherence continues to rise with increasing prevalence of chronic conditions, propelling demand for smart pill boxes and bottles.

Dementia and geriatric care remain the key application areas of smart pill boxes and bottles, according to the report. More than 80% of sales is accounted by aging patients and dementia-afflicted population. Cancer management is likely to emerge lucrative in terms of applicability in coming years.

With surging demand for high-quality healthcare delivery, senior care centers, hospitals, long-term care centers, and homecare settings are accelerating adoption of medication dispensers, thereby elevating the revenue growth of smart pill boxes and bottles market. Some of the leading companies are actively involved in the development of advanced technology medication dispensing devices with zero error risks during medication.

Home care settings maintain the highest consumption share in smart pill boxes and bottles market that roughly equates 65% of total sales. Almost a fifth of smart pill boxes and bottles sold are installed at seniors care and assisted living centers. FMI’s analysis indicates that long-term care centers are also creating promising market opportunities for smart pill boxes and bottles manufacturers and distributors.

North America continues to reign supreme owing to early adoption of advanced technology enabled smart pill boxes and bottles, accounting for more than a third of the global market revenue. European market for smart pill boxes and bottles also represents a substantial volume share, majorly driven by German patients. South and East Asian regions are briskly developing high-potential markets for manufacturers and distributors of smart pill boxes and bottles, says the report.

The vendor landscape of smart pill boxes and bottles market remains fairly consolidated and competitive, as Tier 1 manufacturers continue to account for a majority of share in the market in terms of volume. While dominance of Koninklijke Philips N.V., PharmRight Corporation & Livi, and AdhereTech prevails in smart pill boxes and bottles market, the report finds that the competition among these players is characterized by product innovation, new launches, and technological advancements.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1710

Key Segment

By product type

Smart Pill Box

Smart Pill Bottles

By indication

dementia

Parkinson’s disease

cancer management

diabetes care

geriatric care

disability

others

By end user

Seniors Care & Assisted Living

Long Term Care Centers

Home Care Settings

By regions

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East & Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[241 Pages Report] According to the latest market report published by Future Market Insights titled “Behavioural Health Market: Global Industry Analysis 2013–2021 and Opportunity Assessment 2022–2028”, the global behavioural health market is expected to expand at 3.4% CAGR over the forecast period 2022-2028.